Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

Future OncologyAhead of Print Letter to the EditorSignificant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinomaAleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach & Charles B SimoneAleena MalikTemerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaSearch for more papers by this author, Meghan P JairamBrigham & Women’s Hospital, Harvard Medical School, Boston, MA, USASearch for more papers by this author, Ronald Chow https://orcid.org/0000-0001-6195-8624Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaNew York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this author, Seyed A MirshahvaladTemerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaSearch for more papers by this author, Patrick Veit-HaibachTemerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaSearch for more papers by this author & Charles B Simone *Author for correspondence: E-mail Address: csimone@nyproton.comhttps://orcid.org/0000-0002-0867-3694New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this authorPublished Online:14 Mar 2023https://doi.org/10.2217/fon-2022-0713AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View article"Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma." Future Oncology, 0(0), pp. –References1. Chow R, Simone CB 2nd, Jairam MP, Swaminath A, Boldt G, Lock M. Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses. Acta Oncol. 61(4), 495 (2022).Crossref, Medline, CAS, Google Scholar2. Chow R, Simone CB 2nd, Jairam MP, Swaminath A, Boldt G, Lock M. Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer – a systematic review and network meta-analysis of survival data. Acta Oncol. 61(4), 484–494 (2022).Crossref, Medline, Google Scholar3. Jang WI, Kim MS, Bae SH et al. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat. Oncol. 8(1), 250 (2013).Crossref, Medline, Google Scholar4. Malik A, Jairam MP, Chow R, Mirshahvalad SA, Veit-Haibach P, Simone CB 2nd. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression. Future Oncol. 17(30), 4027–4040 (2022).Google ScholarFiguresReferencesRelatedDetails Ahead of Print eToC Sign up Follow us on social media for the latest updates Metrics Downloaded 9 times History Received 9 September 2022 Accepted 31 January 2023 Published online 14 March 2023 Information© 2023 Future Medicine LtdFinancial & competing interests disclosureThis research was funded, in part, through the NIH/NCI Cancer Center Support Grant P30 CA008748. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download